This statistic depicts the estimated avoidable healthcare costs due to delayed evidence-based treatment practice in the United States in 2012, by disease. In that year, atrial fibrillation was estimated to create a total of 0.7 billion U.S. dollars in avoidable costs. Total avoidable delayed evidence-based treatment practice healthcare costs reached 39.5 billion U.S. dollars in that year. Expected increase in insurance coverage, chronic diseases, and an aging population may place further stresses on the need for proper medication use to prevent avoidable healthcare costs.
Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Health expenditures in the U.S.
Global comparison
4
- Basic Statistic Estimated global per capita health spending 2019 & 2050
- Premium Statistic Per capita health expenditure in selected countries 2020
- Premium Statistic Health expenditure as a percentage of GDP in select countries 2020
- Basic Statistic Countries with highest government health expenditure share 2019
Overview U.S.
4
Categories
4
- Premium Statistic Health spending distribution in the United States by category 2013-2020
- Premium Statistic Health spending growth rate in the U.S. 2020, sorted by category
- Basic Statistic Growth in health spending categories in the U.S. 2013-2020
- Basic Statistic Health spending distribution in the United States by payer 2018-2020
Payer
4
- Premium Statistic U.S. health care expenditure distribution by payer 2015-2022
- Basic Statistic Change in health spending levels in the United States by payer 2020
- Basic Statistic Hospital care spending in the United States by payer 2013-2019
- Basic Statistic Prescription drugs spending in the U.S. by payer 2013-2020
Out-of-pocket
5
- Basic Statistic U.S. total out-of-pocket health care payments 1960-2021
- Premium Statistic U.S. per capita out-of-pocket health care payments 2014-2021
- Premium Statistic Out-of-pocket share of total U.S. personal health care expenditures 2010-2021
- Basic Statistic U.S. out-of-pocket health care payments annual change 2010-2021
- Basic Statistic Health costs distribution of private insurance and out-of-pocket payments U.S. 2020
NHE projections
3
Further related statistics
14
- Avoidable delayed treatment U.S. healthcare costs by settings of care 2012
- Avoidable nonadherence U.S. healthcare costs by settings of care 2012
- Avoidable U.S. healthcare costs by segment 2012
- Avoidable U.S. healthcare costs by area 2012
- Avoidable antibiotics outpatient prescriptions in the U.S. by disease 2012
- Avoidable outpatient antibiotics prescriptions costs in the U.S. by disease 2012
- Avoidable U.S. medication error healthcare costs by settings of care 2012
- Avoidable U.S. healthcare costs due to antiobiotics misuse by settings 2012
- Share of U.S. healthcare spending by percentiles of the population 2012
- Monthly CPI of healthcare services and health spending in Italy 2019-2022
- Health spending in Haiti as share of GDP 2010-2019
- Health spending in Saint Vincent & the Grenadines as share of GDP 2010-2019
- Cost savings in healthcare through mobile health 2014
- Per person costs of treatments for influenza in the U.S. by type 2016-2017
Further Content: You might find this interesting as well
Statistics
- Avoidable delayed treatment U.S. healthcare costs by settings of care 2012
- Avoidable nonadherence U.S. healthcare costs by settings of care 2012
- Avoidable U.S. healthcare costs by segment 2012
- Avoidable U.S. healthcare costs by area 2012
- Avoidable antibiotics outpatient prescriptions in the U.S. by disease 2012
- Avoidable outpatient antibiotics prescriptions costs in the U.S. by disease 2012
- Avoidable U.S. medication error healthcare costs by settings of care 2012
- Avoidable U.S. healthcare costs due to antiobiotics misuse by settings 2012
- Share of U.S. healthcare spending by percentiles of the population 2012
- Monthly CPI of healthcare services and health spending in Italy 2019-2022
- Health spending in Haiti as share of GDP 2010-2019
- Health spending in Saint Vincent & the Grenadines as share of GDP 2010-2019
- Cost savings in healthcare through mobile health 2014
- Per person costs of treatments for influenza in the U.S. by type 2016-2017
IMS Health. (June 28, 2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* [Graph]. In Statista. Retrieved January 31, 2023, from https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*." Chart. June 28, 2013. Statista. Accessed January 31, 2023. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. (2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: January 31, 2023. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable Healthcare Costs Due to Delayed Treatment Practice in The U.S. in 2012, by Disease (in Billion U.S. Dollars)*." Statista, Statista Inc., 28 Jun 2013, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health, Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/ (last visited January 31, 2023)
Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* [Graph], IMS Health, June 28, 2013. [Online]. Available: https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/